Literature DB >> 29144206

C-Jun expression in lichen planus, psoriasis, and cutaneous squamous cell carcinoma, an immunohistochemical study.

Asmaa Gaber Abdou1, Alaa Hassan Marae2, Mohammed Shoeib2, Ghada Dawood3, Enas Abouelfath3.   

Abstract

The AP-1 transcription factor complex is a key player in regulating inflammatory processes, cell proliferation, differentiation, and cell transformation. The aim of the present study is to investigate C-Jun (one of AP-1complex) expression and its proliferative role in skin samples of lichen planus, psoriasis as common inflammatory skin diseases and squamous cell carcinoma using immunohistochemical method. The present study was carried out on skin biopsies of 15 psoriatic patients, 15 lichen planus patients, 15 SCC, and 15 normal skin biopsies. Nuclear expression of C-Jun was detected in basal and few suprabasal layers of epidermis of normal skin. C-Jun was expressed in the whole epidermal layers of both psoriasis (14/15) and lichen planus (15/15) in addition to its expression in lymphocytic infiltrate in the latter in about half of cases (8/15). C-Jun was also expressed in 93.3% (14/15) of SCC in a percentage lower than that of psoriasis, lichen planus, and normal skin. The percentage of C-Jun expression in SCC was significantly associated with an early stage (p = 0.000), free surgical margins (p = 0.022), and small tumour size (p = 0.003).
CONCLUSIONS: The marked reduction of C-Jun in SCC in comparison to normal skin and inflammatory skin dermatoses may refer to its tumour suppressor activity. C-Jun expression in SCC carries favourable prognosis. Absence of significant association between C-Jun and Ki-67 either in SCC or inflammatory skin diseases indicates that it does not affect proliferative capacity of cells.

Entities:  

Keywords:  C-Jun; KI-67; SCC; lichen planus; psoriasis

Mesh:

Substances:

Year:  2018        PMID: 29144206     DOI: 10.1080/15321819.2017.1395347

Source DB:  PubMed          Journal:  J Immunoassay Immunochem        ISSN: 1532-1819


  3 in total

1.  Investigation on the Mechanism of Qubi Formula in Treating Psoriasis Based on Network Pharmacology.

Authors:  Lin Zhou; Lingyun Zhang; Disheng Tao
Journal:  Evid Based Complement Alternat Med       Date:  2020-06-21       Impact factor: 2.629

2.  Giant Squamous Cell Carcinoma on Chronic Lichen Planus on the Ankle - A Case Report and Short Literature Review.

Authors:  Uwe Wollina; Claudia Krönert; Jacqueline Schönlebe; Aleksandra Vojvodic; Torello Lotti
Journal:  Open Access Maced J Med Sci       Date:  2019-08-19

3.  Fisetin, a 3,7,3',4'-Tetrahydroxyflavone Inhibits the PI3K/Akt/mTOR and MAPK Pathways and Ameliorates Psoriasis Pathology in 2D and 3D Organotypic Human Inflammatory Skin Models.

Authors:  Jean Christopher Chamcheu; Stephane Esnault; Vaqar M Adhami; Andrea L Noll; Sergette Banang-Mbeumi; Tithi Roy; Sitanshu S Singh; Shile Huang; Konstantin G Kousoulas; Hasan Mukhtar
Journal:  Cells       Date:  2019-09-15       Impact factor: 6.600

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.